Cargando…
Modeling of lung phenotype of Hermansky–Pudlak syndrome type I using patient-specific iPSCs
BACKGROUND: Somatic cells differentiated from patient-specific human induced pluripotent stem cells (iPSCs) could be a useful tool in human cell-based disease research. Hermansky–Pudlak syndrome (HPS) is an autosomal recessive genetic disorder characterized by oculocutaneous albinism and a platelet...
Autores principales: | Suezawa, Takahiro, Kanagaki, Shuhei, Korogi, Yohei, Nakao, Kazuhisa, Hirai, Toyohiro, Murakami, Koji, Hagiwara, Masatoshi, Gotoh, Shimpei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570015/ https://www.ncbi.nlm.nih.gov/pubmed/34736469 http://dx.doi.org/10.1186/s12931-021-01877-8 |
Ejemplares similares
-
Directed induction of alveolar type I cells derived from pluripotent stem cells via Wnt signaling inhibition
por: Kanagaki, Shuhei, et al.
Publicado: (2020) -
In Vitro Disease Modeling of Hermansky-Pudlak Syndrome Type 2 Using Human Induced Pluripotent Stem Cell-Derived Alveolar Organoids
por: Korogi, Yohei, et al.
Publicado: (2019) -
In Vitro Disease Modeling of Hermansky-Pudlak Syndrome Type 2 Using Human Induced Pluripotent Stem Cell-Derived Alveolar Organoids
por: Korogi, Yohei, et al.
Publicado: (2019) -
Disease modeling of pulmonary fibrosis using human pluripotent stem cell-derived alveolar organoids
por: Suezawa, Takahiro, et al.
Publicado: (2021) -
iPSC-derived mesenchymal cells that support alveolar organoid development
por: Tamai, Koji, et al.
Publicado: (2022)